These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 6983324)

  • 1. Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy.
    Hoikka V; Savolainen K; Karjalainen P; Alhava EM; Sivenius J
    Ann Clin Res; 1982 Apr; 14(2):72-5. PubMed ID: 6983324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant osteomalacia in epileptic outpatients.
    Hoikka V; Savolainen K; Alhava EM; Sivenius J; Karjalainen P; Parvianinen M
    Ann Clin Res; 1982 Jun; 14(3):129-32. PubMed ID: 7137882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia.
    Collins N; Maher J; Cole M; Baker M; Callaghan N
    Q J Med; 1991 Feb; 78(286):113-22. PubMed ID: 1851568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anticonvulsant osteomalacia with vitamin D.
    Christiansen C; Rodbro P
    Calcif Tissue Res; 1976 Aug; 21 Suppl():252-9. PubMed ID: 782665
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of long term anticonvulsant therapy on serum calcium, phosphate and alkaline phosphatase in Nigerian epileptic patients.
    Apantaku JB; Afonja OA; Boyo AE
    Trop Geogr Med; 1975 Dec; 27(4):418-21. PubMed ID: 1216324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteomalacia with long-term anticonvulsant therapy in epilepsy.
    Dent CE; Richens A; Rowe DJ; Stamp TC
    Br Med J; 1970 Oct; 4(5727):69-72. PubMed ID: 5312062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term vitamin D2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia.
    Mosekilde L; Melsen F; Christensen MS; Lund B; Sorenson OH
    Acta Med Scand; 1977; 201(4):303-7. PubMed ID: 300547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: a prospective study.
    Krishnamoorthy G; Nair R; Sundar U; Kini P; Shrivastava M
    Neurol India; 2010; 58(2):213-9. PubMed ID: 20508338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced 2,25-dihydroxyvitamin D and 24,25-dihydroxyvitamin D in epileptic patients receiving chronic combined anticonvulsant therapy.
    Christensen CK; Lund B; Lund BJ; Sørensen OH; Nielsen HE; Mosekilde L
    Metab Bone Dis Relat Res; 1981; 3(1):17-22. PubMed ID: 6973685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of anticonvulsant drug-induced bone disease.
    Drezner MK
    Epilepsy Behav; 2004 Feb; 5 Suppl 2():S41-7. PubMed ID: 15123011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteopathies, calcium- and vitamin D metabolism errors during anti-epileptic long term therapy].
    Kruse R
    Bibl Psychiatr; 1975; (151):114-43. PubMed ID: 168863
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology behind anticonvulsant osteomalacia.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Neurol Scand Suppl; 1983; 94():21-8. PubMed ID: 6576595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy.
    Pylypchuk G; Oreopoulos DG; Wilson DR; Harrison JE; McNeill KG; Meema HE; Ogilvie R; Sturtridge WC; Murray TM
    Can Med Assoc J; 1978 Mar; 118(6):635-8. PubMed ID: 418865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D.
    Davie MW; Emberson CE; Lawson DE; Roberts GE; Barnes JL; Barnes ND; Heeley AF
    Q J Med; 1983; 52(205):79-91. PubMed ID: 6603629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia.
    Christiansen C; Rodbro P; Munck O
    Br Med J; 1975 May; 2(5967):363-5. PubMed ID: 165857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial and maintenance dose of vitamin D2 in the treatment of anticonvulsant osteomalacia.
    Christiansen C; Rodbro P
    Acta Neurol Scand; 1974; 50(5):631-41. PubMed ID: 4547902
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment with high-dose oral vitamin D2 in patients with jejunoileal bypass for morbid obesity. Effects on calcium and magnesium metabolism, vitamin D metabolites, and faecal lag time.
    Charles P; Mosekilde L; Søndergård K; Jensen FT
    Scand J Gastroenterol; 1984 Nov; 19(8):1031-8. PubMed ID: 6335925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy.
    Hoikka V; Savolainen K; Alhava EM; Sivenius J; Karjalainen P; Repo A
    Acta Neurol Scand; 1981 Aug; 64(2):122-31. PubMed ID: 7324878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant drug therapy in human pregnancy: effects on serum concentrations of vitamin D metabolites in maternal and cord blood.
    Markestad T; Ulstein M; Strandjord RE; Aksnes L; Aarskog D
    Am J Obstet Gynecol; 1984 Oct; 150(3):254-8. PubMed ID: 6091458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term effects of anti-epileptic treatment on the blood calcium, phosphates and alkaline phosphatase].
    Gasparoni MC; Martini C; Garibaldi E; Colombo A
    Minerva Pediatr; 1977 Jun; 29(21):1373-7. PubMed ID: 882080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.